- Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma, Xiao-Meng Dai, Tao Huang, Sheng-Li Yang, Xiu-Mei Zheng, George G. Chen, and Tao Zhang
Disease Markers
Research Article (8 pages), Article ID 8495326, Volume 2017 (2017)
Published 10 May 2017
Disease Markers
Volume 2017, Article ID 3765279, 1 page
https://doi.org/10.1155/2017/3765279
Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Pediatrics, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430064, China
3Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
Correspondence should be addressed to Sheng-Li Yang; moc.liamg@3102uodnefuxij and Tao Zhang; moc.kooltuo@66gnahzoat
Received 11 July 2017; Accepted 6 August 2017; Published 20 September 2017
Copyright © 2017 Xiao-Meng Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the article titled “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma” [1], affiliation number one was given incorrectly. The corrected affiliation is shown above.
References
- X.-M. Dai, T. Huang, S.-L. Yang, X.-M. Zheng, G. G. Chen, and T. Zhang, “Peritumoral EpCAM is an independent prognostic marker after curative resection of HBV-related hepatocellular carcinoma,” Disease Markers, vol. 2017, Article ID 8495326, 8 pages, 2017. View at Publisher · View at Google Scholar